InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+39.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Erck Stanley C, 董事长兼首席执行官. Insider active across 2 companies, notably NOVAVAX INC. Cumulatively, 15 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €117k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 13 August 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Erck Stanley C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
30,421 股Common StockSEC:0000905148-26-003054:0
100,000 股@ US$1.372297.2% 占其流量Common StockSEC:0000905148-25-002875:0
标准退出：2025年11月11日 (T+90)
29,210 股0Common StockSEC:0000905148-25-002233:0
47,689 股@ US$0.0452.4% 占其流量Common StockSEC:0001415889-24-026144:0
26,082 股@ US$0.0428.2% 占其流量Common StockSEC:0001415889-24-024454:0
17,922 股@ US$0.0419.4% 占其流量Common StockSEC:0001415889-24-022941:0
21,367 股0Common StockSEC:0001415889-24-016711:0
6,966 股Common StockSEC:0001209191-22-061699:0
6,546 股Common StockSEC:0001209191-22-051472:0
6,967 股Common StockSEC:0001209191-21-070007:0
14,000 股@ US$27.6023.5% 占其流量Common StockSEC:0001209191-21-059552:0
32,000 股@ US$27.6053.5% 占其流量Common StockSEC:0001209191-21-059557:0
6,546 股Common StockSEC:0001209191-21-057939:0
15,181 股@ US$25.6023.1% 占其流量Common StockSEC:0001209191-21-045558:0
2,072 股Common StockSEC:0001209191-16-094479:0
标准退出：2016年4月30日 (T+90)
15 条申报中的 15 条
About Erck Stanley C
Erck Stanley C is President and CEO. He has 15 filings in total, and across the sampled recent filings covering the period from 2016-02-01 to 2026-06-22, the buy volume is EUR 117153 and the sell volume is EUR 0, with the most frequent transaction nature listed as Levée d'options. He is also linked to NOVAVAX INC as President and CEO and to Maxcyte, INC. as Director.
